Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204


Become EABM
Become Reviewer

Spermine Metabolism and Anticancer Therapy

Volume:9   Issue: 2
Pp: 118-130
R. Amendola, M. Cervelli, E. Fratini, F. Polticelli, D. E. Sallustio and P. Mariottini
DOI: 10.2174/156800909787580935

Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer

Volume:9   Issue: 2
Pp: 148-162
Philippe L. Bedard, Evandro de Azambuja and Fatima Cardoso
DOI: 10.2174/156800909787581024

Role of the Akt Pathway in Prostate Cancer

Volume:9   Issue: 2
Pp: 163-175
Paul L. de Souza, Pamela J. Russell and John Kearsley
DOI: 10.2174/156800909787581006

Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System

Volume:9   Issue: 2
Pp: 176-188
Michael A. Grotzer, Deborah Castelletti, Giulio Fiaschetti, Tarek Shalaby and Alexandre Arcaro
DOI: 10.2174/156800909787580962

Elucidation of the Molecular Mechanisms of a Salicylhydrazide Class of Compounds by Proteomic Analysis

Volume:9   Issue: 2
Pp: 189-201
Xuefei Cao, Carmen Plasencia, Atsuko Kanzaki, Austin Yang, Terrence R. Burke Jr. and Nouri Neamati
DOI: 10.2174/156800909787580971

Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells

Volume:9   Issue: 2
Pp: 202-213
R. Pignatello, D. Paolino, V. Panto, V. Pistara, M. G. Calvagno, D. Russo, G. Puglisi and M. Fresta
DOI: 10.2174/156800909787580944

Nitric Oxide: Cancer Target or Anticancer Agent?

Volume:9   Issue: 2
Pp: 214-236
Simone Mocellin
DOI: 10.2174/156800909787581015

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Volume:9   Issue: 2
Pp: 237-249
Todd M. Morgan, Theodore D. Koreckij and Eva Corey
DOI: 10.2174/156800909787580999